Suggestions
Stephen Yelity
Facilitating the partnering of biotech startups with investors & business development executives at pharma companies.
Stephen Yelity is a skilled professional with a background in accounting, business administration, and biotech. He is the founder and CEO of BusStim, a company dedicated to assisting biotech startups in becoming investment-ready by connecting them with investors and pharma industry professionals. By evaluating the origins of startups, assessing their intellectual property, and enhancing their management teams, BusStim aims to improve the success of early-stage biotech companies. Through a thorough due diligence process encompassing scientific, market, and legal analysis, BusStim prepares startups for investor presentations and pharma collaborations. With a Bachelor of Science degree in Accounting & Business Administration from Norfolk State University, Stephen Yelity has held key roles in various organizations, including serving as the Regional Director at JFL Enterprises, Inc., Independent Consultant at BD Consulting, President & CEO at ACCURATE Information Systems Inc, and Manager of Cost Accounting at Johnson & Johnson.
Highlights
Michelle McMurry-Heath #Kudos #ThankYou BIO In-person is back!!! This conference was well organized and well attended!! I cannot wait for Boston 2023!!!
Raising capital for early-stage opportunities is a challenge. We are investigating an alternative vehicle for raising seed capital. One of our partner companies – Corvidane – is successfully using a new Crown Funding method named Reg. CF. This is an opportunity for non-accredited investors to contribute to life-saving R&D.
Corvidane has a new Omega-7/Omega-9 fatty acid product in early-stage development for NASH (non-alcoholic fatty liver disease) and atherosclerosis.
Please review Corvidane’s WeFunder campaign https://lnkd.in/gftACv6Y They have raised $145K but are still looking for a Reg CF lead investor. The Lead investor of the Reg. CF would manage the funds of the SPV. What is a Lead Investor https://lnkd.in/gftACv6Y This Reg. CF investment events can be grouped into an SPV, therefore, enabling the Series A investors to manage that pool of money as they would a convertible note or SAFE.
